Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 14,000 | |||
5 mg | 在庫あり | ¥ 34,000 | |||
10 mg | 在庫あり | ¥ 58,000 | |||
25 mg | 在庫あり | ¥ 114,000 | |||
50 mg | 在庫あり | ¥ 170,500 | |||
100 mg | 在庫あり | ¥ 241,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
別名 | DWK-1339 |
分子量 | 326.39 |
分子式 | C20H22O4 |
CAS No. | 1018946-38-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (245.11 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MDR-1339 1018946-38-7 Neuroscience Proteases/Proteasome Stem Cells Beta Amyloid Gamma-secretase inhibit DWK-1339 β-amyloid peptide Inhibitor DWK1339 MDR 1339 Abeta Amyloid-β MDR1339 DWK 1339 inhibitor